Pichia pastoris: an eukariotic system for the expression of recombinant therapeutic molecules

Rationally designed anticancer agents targeting cell-surface antigens or receptors, such as Immunotoxins, represent a promising approach for treating cancer patients. The Immunotoxin IL4PE40 derives its activity to induce apoptosis from the 40 kDa PE fragment (Pseudomonas exotoxin A) and its specificity from the permuted form of interleukin-4. IL4PE40 produced in E. coli was extracted from inclusion bodies and purified by affinity chromatography, in its active form. However, the clinical translation of therapeutic molecules produced in E. coli is often difficult, due to endotoxin contaminations and laborious protocols of inclusion bodies purification that make hard the reproducibility of the isolation procedures. To overcome these disadvantages, I cloned the IL4PE40 gene into a yeast expression vector for use in the Pichia pastoris yeast. In the literature it is reported that P. pastoris can secrete grams per liter of foreign proteins in a protein-poor medium that is inexpensive and chemically defined. The presence of a signal peptide at the N-terminus of the recombinant protein allows the secretion of native protein within the culture medium. In addition, the low level of endogenous proteins secreted in the culture medium facilitates the purification steps of the final product. In my work the yield of IL4PE40 produced by yeast was optimized by yeast codon usage and by testing different induction conditions. After optimization the yeast P. pastoris was able to produce 120 µg of full-length Immunotoxin from 1 liter of culture, which is far from results obtained with non-toxic proteins by other workers. Moreover, although after optimization the yield increased, proteins obtained from optimized cultures of P. pastoris show a considerable level of degradation. The translocation of toxic fusion proteins in the cytosol during biosynthesis may lead to such low protein production. Additionally, it appears that proteases cleaving the recombinant molecules cold be present in the yeast medium. Preliminary cleavage assays with native PE and literature data suggest that several proteases (serine proteases and subtilisins) could cooperate in the IL4PE40 cleavage. Planned experiments to overcome these limitations are also described in my thesis.